News

Dr Jessamy Tiffen, Head of the Centenary Institute’s Epigenetics of Melanoma Program, has been an invited panel guest at a special leadership event hosted by the law firm Jones Day.

Research conducted at the Centenary Institute has unveiled crucial insights into the underlying molecular mechanisms of breast cancer. The findings could lead to a more effective treatment for the disease, which claims the lives of over 3,000 Australian women and men annually.

You may have wondered what makes stem cells so important and why they are needed for medical research.

Dr Dannel Yeo from the Centenary Institute and Clinical Associate Professor Kate Mahon from Chris O’Brien Lifehouse, have been awarded an inaugural Sydney Cancer Partners Translational Fellowship.

The Centenary Institute has given members of the public, school students and stakeholders the opportunity to find out what it’s like to be a scientist – and to better understand what it takes to be at the cutting-edge of medical discovery – with its unique ‘speed dating’ event, held as part of the Spark Festival.

The Centenary Institute has engaged with kids and the wider community as the Research Partner of Sydney Science Trail held at the Botanic Gardens and Australian Museum in celebration of National Science Week.

Dr Jessamy Tiffen has been promoted to the Scientific Faculty at the Centenary Institute where she will be a part of the senior science leadership team.

A new study from German and Centenary Institute researchers has provided new understanding of an enzyme called dipeptidyl peptidase 9 (DPP9) and its role in cancer development.

Dr Annalicia Vaughan from the Centenary UTS Centre for Inflammation is the successful recipient of the Kenyon Foundation Inflammation Award for 2022. The Award, valued at $20,000, will support Dr Vaughan’s study into identifying new microbial-derived biomarkers for the early diagnosis and treatment of lung cancer. The leading cause of cancer death, lung cancer is ...

World-leading research into pancreatic cancer has been boosted with the Centenary Institute’s Professor John Rasko AO awarded a $100,000 ‘Innovation in Early Detection’ grant from The Australian Pancreatic Cancer Foundation. One of the deadliest forms of cancer, the five-year survival rate for pancreatic cancer is less than 12% in Australia. A reason for the low ...

The Centenary Institute’s Dr Madeleine Gill has today received a National Health and Medical Research Council (NHMRC) postgraduate scholarships grant to continue her research into understanding unexplained heart failure in patients with liver cirrhosis. Cirrhotic cardiomyopathy affects approximately 50 per cent of patients with cirrhosis and can be a barrier to liver transplantation and is ...

Professor Philip Hogg, Head, ACRF Centenary Cancer Research Centre, has featured on Nine News explaining his new theranostics research, recently funded by the Cancer Institute NSW. A form of personalised cancer treatment for the patient, the term ‘theranostics’ refers to a combined therapy and diagnostics approach where tumour markers are employed to deliver a therapeutic isotope ...